Intravenous proton pump inhibitors vs oral potassium competitive acid blockers before endoscopic treatment of bleeding peptic ulcers

Table 2 Multivariate analysis related to therapeutic intervention

Variables	OR	95%CI	P value
Age (year), mean ± SD	1.005	0.972-1.039	0.777
Male sex	0.548	0.184-1.632	0.280
Helicobacter pylori infection	1.331	0.528-3.356	0.544
Use of anti-coagulants	0.994	0.193-5.120	0.994
Use of anti-platelet	1.299	0.493-3.423	0.596
PCAB (vs PPI)	0.272	0.111-0.665	0.004a

^aStatistically significant.

CI: Confidence interval; OR: Odds ratio; PPI: Proton pump inhibitor; PCAB: Potassium competitive acid blocker.